Zohre MOMENİMOVAHED, Mahshid GHONCHEH, Reza PAKZAD, Hamid HASANPOUR, Hamid SALEHİNİYA

Uterus kanser insidansı ve mortalitesi, ve dünyada İnsani Gelişme İndeksi ile ilişkisi

Amaç: Bu çalışmanın amacı uterus kanser insidans ve mortalitesinin, İnsani Gelişme Indeksi (HDI) ve bunun 2012’deki komponentleri ile arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntem: Bu çalışmada kullanılan veriler, 2012 yılında GLOBOCAN tarafından sunulan insidans ve ölüm oranlarında elde edilmiştir. HDI ve bileşenleri hakkındaki veriler Dünya Bankası sitesinden alınmıştır. HDI ve komponentleri ile Standart Mortalite Oranları (SMH) ve Standart İnsidans Hızları (SIH) arasındaki korelasyonun değerlendirilmesi için iki değişkenli korelasyon yöntemi kullanıldı. Bulgular: Toplamda 2012'de dünyadaki tüm ülkelerde prostat kanseri için 52762 insidans vakası ve 265672 ölüm kaydedildi.Serviks uteri kanseri için SMH, tüm dünyada yüz bin kişi için 6.8 olarak saptandı. Uterus kanseri SIH ile HDI arasında -0.578'lik negatif korelasyon saptandı. Ayrıca, uterus kanseri (SMH) ile HDI arasında-0.717'lik negatif korelasyon saptandı. Sonuç: Bu çalışmanın sonuçları, az gelişmiş ülkelerde uterus kanser insidansının ve mortalitesinin daha yüksek olduğunu ve insidansın HDI ile pozitif ilişkili olduğunu göstermektedir. Sonuç olarak, etkili ve kabul edilebilir tarama programlarının yaygınlaştırılmasının kanser insidansını etkili bir şekilde azaltabileceği düşünülmektedir.

Anahtar Kelimeler:

İnsidans, mortalite, uterin kanseri

The incidence and mortality of uterine cancer and their relationship with human development index in the world

Purpose: The aim of this study was to evaluate the incidence, mortality of uterine cancer, their relationship with Human Development Index (HDI), and its components in world in 2012.Material and Methods: Data were obtained from incidence and mortality rates presented by GLOBOCAN in 2012. Data on HDI and its components were extracted from the World Bank site. We used the correlation bivariate method for assessment of the correlation between Standardized Mortality Rates (SMRs) and Standardized Incidence Rates with HDI, and its details. Results: In total, 52762 incidence cases and 265672 deaths of prostate cancer were recorded in 2012 in all countries in the world. ASMR for cervix uteri cancer was 6.8 per hundred thousand people in the entire world and ASMR for cervix uteri cancer was 6.8 per hundred thousand people in the entire world.A negative correlation of -0.578 was seen between SIR of uterine cancer and HDI. Also, a negative correlation of -0.717 was seen between SMR of uterine cancer and HDI. Conclusion: The results of this study show that the incidence and mortality of uterine cancer is higher in less developed countries and incidence is positively significantly related to HDI. Finally, the expansion of effective, acceptable screening programs can effectively reduce the incidence of Cancer.

Keywords:

Incidence, mortality, uterine cancer,

PDF

___

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, CA Cancer J Clin. 2015;65:5-29.
2. Nikfarjam Z, Massoudi T, Salehi M, Salehi M, Khoshroo F. Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades. Asian Pac J Cancer Prev. 2014;15:10193-98.
3. Eberth JM, Prarelkar P, Nguyen H, Sun C, Irvin-Vidrine J, Elting LS. The human and economic burden of cervical cancer in Texas. Tex Public Health J. 2013;65:51.
4. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1:505-27.
5. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, IARC, 2013.
6. Beavis AL, Levinson KL. Preventing cervical cancer in the united states: barriers and resolutions for HPV vaccination. Front Oncol. 2016;6.
7. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147-72.
8. Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15:1.
9. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103:368-83.
10. Binswanger IA, Mueller S, Clark CB, Cropsey KL. Risk factors for cervical cancer in criminal justice settings. J Womens Health. 2011;20:1839-45.
11. Fonseca-Moutinho JA. Smoking and cervical cancer. ISRN Obstet Gynecol. 2011;2011:847684.
12. Lee JK, So KA, Piyathilake CJ, Kim MK. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PloS One. 2013;8:e66555.
13. Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA et al. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013;128:265-70.
14. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.
15. Aminisani N, Armstrong BK, Egger S, Canfell K. Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia. BMC Cancer. 2012;12:1.
16. Tabatabai MA, Kengwoung-Keumo J-J, Eby WM, Bae S, Guemmegne JT, Manne U et al. Disparities in Cervical Cancer Mortality Rates as Determined by the Longitudinal Hyperbolastic Mixed-Effects Type II Model. PloS One. 2014;9:e107242.
17. Pakzad R, Mohammadian-Hafshejani A, Khosravi B, Soltani S, Pakzad I, Salehiniya H et al. The incidence and mortality of esophageal cancer and their relationship to development in Asia. Ann Transl Med. 2016;4(2):29.
18. Ghoncheh M, Mirzaei M, Salehiniya H. Incidence and mortality of breast cancer and their relationship with the Human Development Index (HDI) in the world in 2012. Asian Pac J Cancer Prev. 2015;16:8439-43.
19. Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, Pakzad I, Salehiniya H. The incidence and mortality of lung cancer and their relationship to development in Asia. Transl Lung Cancer Res. 2015;4:763-74.
20. Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, Pakzad I, Salehiniya H. The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int. 2015;3:135-40.
21. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality. Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. (Accessed on 2/2/2017).
22. Malik K. Human development report 2013. The rise of the south: Human progress in a diverse world. The Rise of the South: Human Progress in a Diverse World (March 15, 2013) UNDP-HDRO Human Development Reports. 2013.
23. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.
24. Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z, Salehiniya H. Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pac J Cancer Prev. 2015;17:381-6.
25. Tota J, Ramana–Kumar A, El-Khatib Z, Franco E. The road ahead for cervical cancer prevention and control. Curr Oncol. 2014;21:e255.
26. Bergot A-S, Kassianos A, Frazer IH, Mittal D. New approaches to immunotherapy for HPV associated cancers. Cancers. 2011;3:3461-95.
27. Fernandes TAAdM, Meissner RdV, Bezerra LF, Azevedo PRMd, Fernandes JV. Human papillomavirus infection in women attended at a cervical cancer screening service in Natal, Brazil. Braz J Microbiol. 2008;39:573-78.
28. Schuster M, WHO G. Human papillomavirus vaccines: WHO position paper, October 2014-Recommendations. 2015.
29. Jia Y, Li S, Yang R, Zhou H, Xiang Q, Hu T et al. Knowledge about cervical cancer and barriers of screening program among women in Wufeng County, a high-incidence region of cervical cancer in China. PloS One. 2013;8:e67005.
30. Bayu H, Berhe Y, Mulat A, Alemu A. Cervical Cancer Screening Service Uptake and Associated Factors among Age Eligible Women in Mekelle Zone, Northern Ethiopia, 2015: A Community Based Study Using Health Belief Model. PloS One. 2016;11:e0149908.
31. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
32. El Ibrahimi S. The effect of marriage on stage at diagnosis and survival in women with cervical cancer. Psychooncology. 2013.
33. Kanavos P. The rising burden of cancer in the developing world. Ann Oncol. 2006;17(Suppl 8):viii15-23.
34. Shack L, Jordan C, Thomson CS, Mak V, Møller H. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer. 2008;8:271.
35. Akinyemiju TF. Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PloS One. 2012;7:e48834.
36. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011:2675-86.
37. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia. Asian Pac J Cancer Prev. 2015;16:6081-7.
38. Muhamad N, Kamaluddin M, Adon M, Noh M, Bakhtiar M, Ibrahim TN et al. Survival rates of cervical cancer patients in malaysia. Asian Pac J Cancer Prev. 2014;16:3067-72.
39. Mbulawa ZZ, Marais DJ, Johnson LF, Boulle A, Coetzee D, Williamson A-L. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. J Gen Virol. 2010;91:3023-31.
40. Freitas B, Suehiro T, Consolaro M, Silva V. HPV Infection and cervical abnormalities in HIV positive women in different regions of Brazil, a middle-income country. Asian Pac J Cancer Prev. 2014;16:8085-91.